IP Library Granted Patent US 7,326,696
Granted Patent B2
US 7,326,696 · App. 10/737,361 · Granted Feb 5, 2008

Amino-methyl substituted tetracycline compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,326,696
App. No.
10/737,361
Granted
Feb 5, 2008
Kind
B2
Abstract

Aminomethyl substituted tetracycline compounds, pharmaceutical compositions, and methods of use thereof are discussed.

Claims (258)

1. A tetracycline compound of formula (III):

wherein:

J 5 and J 6 are each independently hydrogen, alkyl, alkenyl, alkynyl, aryl, sulfonyl, acyl, alkoxycarbonyl, alkaminocarbonyl, alkaminothiocarbonyl, substituted thiocarbonyl, substituted carbonyl, alkoxythiocarbonyl, or linked to form a ring;

J 7 and J 8 are each alkyl, halogen, or hydrogen;

X is CR 6′ R 6 ;

R 2 , R 2′ ,R 4′ , and R 4″ are each independently hydrogen, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, aryl, heterocyclic, heteroaromatic or a prodrug moiety;

R 4 is NR 4′ R 4″ , alkyl, alkenyl, alkynyl, aryl, hydroxyl, halogen, or hydrogen;

R 3 , R 10 , R 11 and R 12 are each hydrogen or a pro-drug moiety;

R 5 is hydroxyl, hydrogen, thiol, alkanoyl, aroyl, alkaroyl, aryl, heteroaromatic, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, arylalkyl, alkyl carbonyloxy, or aryl carbonyloxy;

R 6 and R 6′ are each independently hydrogen, methylene, absent, hydroxyl, halogen, thiol, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or an arylalkyl;

R 7 is hydrogen, ethyl, phenyl, 4-t-butylphenyl, t-butylaminophenyl or dimethylamino;

R 8 is hydrogen, hydroxyl, halogen, thiol, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or an arylalkyl;

R 13 is hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, or an arylalkyl; and

pharmaceutically acceptable salts thereof.

2. The tetracycline compound of claim 1 , wherein R 4 is NR 4′ R 4″ , X is CR 6 R 6′ ; R 2 , R 2′ , R 6 , R 6′, R 8 , R 10 , R 11 , and R 12 are each hydrogen; R 4′ and R 4″ are lower alkyl; and R 5 is hydroxyl or hydrogen.

3. The tetracycline compound of claim 2 , wherein R 4′ and R 4″ are each methyl and R 5 is hydrogen.

4. The tetracycline compound of claim 1 , wherein J 7 and J 8 are hydrogen.

5. The tetracycline compound of claim 1 , wherein J 5 is substituted or unsubstituted alkyl.

6. The tetracycline compound of claim 1 , wherein J 5 is sulfonyl.

7. The tetracycline compound of claim 1 , wherein J 5 and J 6 are linked to form a ring.

8. The tetracycline compound of claim 1 , wherein J 5 is heteroaryl.

9. The tetracycline compound of claim 1 , wherein J 5 is substituted carbonyl.

10. The tetracycline compound of claim 1 , wherein said compound is selected from the group consisting of:

wherein

R is substituted or unsubstituted alkyl, alkenyl, alkynyl, halogen, alkoxy; and

Y is N, O, or S, or pharmaceutically acceptable salts or prodrugs thereof.

11. A tetracycline compound selected from the following:

or a pharmaceutically acceptable salt thereof.

12. The compound of claim 1 , wherein R 7 is dimethylamino.

13. The compound of claim 1 or 9 , wherein J 6 is alkyl.

14. The compound of claim 13 , wherein said compound is

and pharmaceutically acceptable salts thereof.

15. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

16. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

17. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

18. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

19. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

20. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

21. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

22. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

23. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

24. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

25. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

26. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

27. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

28. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

29. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

30. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

31. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

32. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

33. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

34. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

35. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

36. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

37. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

38. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

39. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

40. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

41. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

42. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

43. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

44. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

45. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

46. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

47. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

48. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

49. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

50. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

51. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

52. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

53. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

54. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

55. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

56. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

57. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

58. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

59. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

60. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

61. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

62. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

63. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

64. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

65. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

66. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

67. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

68. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

69. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

70. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

71. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

72. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

73. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

74. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

75. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

76. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

77. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

78. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

79. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

80. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

81. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

82. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

83. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

84. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

85. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

86. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

87. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

88. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

89. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

90. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

91. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

92. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

93. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

94. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

95. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

96. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

97. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

98. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

99. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

100. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

101. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

102. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

103. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

104. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

105. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

106. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

107. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

108. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

109. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

110. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

111. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

112. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

113. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

114. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

115. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

116. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

117. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

118. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

119. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

120. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

121. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

122. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

123. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

124. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

125. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

126. The compound of claim 1 , wherein said compound is

and pharmaceutically acceptable salts thereof.

127. A pharmaceutical composition comprising an effective amount of a tetracycline compound of any one of claims 1 , 10 or 11 , and a pharmaceutically acceptable carrier.

128. The pharmaceutical composition of claim 127 , wherein said effective amount is effective to treat a tetracycline responsive state.

Assignments (9)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 065001/0917 Recorded May 22, 2025
From: OAKTREE FUND ADMINISTRATION, LLC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 071343/0407 →
SECURITY INTEREST Recorded Sep 22, 2023
From: PARATEK PHARMACEUTICALS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 065001/0917 →
TERMINATION OF LIEN ON PATENTS Recorded Dec 23, 2014
From: MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034700/0377 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2014
From: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034113/0910 →
SECURITY INTEREST Recorded Mar 14, 2014
From: PARATEK PHARMACEUTICALS, INC.
To: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
Reel/Frame 032448/0001 →
NOTICE Recorded Mar 8, 2013
From: PARATEK PHARMACEUTICALS, INC.
To: MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC
Reel/Frame 029940/0106 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2009
From: MIDCAP FINANCIAL, LLC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 023348/0621 →
SECURITY AGREEMENT Recorded Jul 6, 2009
From: PARATEK PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL, LLC
Reel/Frame 022917/0112 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2004
From: NELSON, MARK L.; OHEMENG, KWASI; FRECHETTE, ROGER; ABATO, PAUL; AMOO, VICTOR; ASSEFA, HAREGEWEIN; BERNIAC, JOEL; BHATIA, BEENA; BOWSER, TODD; CHEN, JACKSON; HONEYMAN, LAURA; ISMAIL, MOHAMED Y.; KIM, OAK; MECHICHE, RACHID; REDDY, N. LAXMA; VERMA, ATUL K.; VISKI, PETER; WARCHOL, TADEUSZ; YANACHKOV, IVAN
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 015240/0402 →